Agenda
Biological
Mechanisms Linking Co-morbid Conditions Associated With Temporomandibular
Joint and Muscle Disorders
Sponsored by
the Temporomandibular Joint and Muscle Disease
Interagency Working Group
Conference
Room 6
Building 31
National
Institutes of Health
Welcome
Dr.
Lawrence Tabak
Background
...Dr.
Norman S. Braveman
Perspectives of Patients and
Patient Advocates:
Awareness, Prevention, and
Patient Research Data: The Role of A TMJ
Advocacy Organization
Mr. Milton L. Glass and Ms.
Renιe Glass
Co-Founders-Presidents, Jaw
Joints & Allied
Musculoskeletal Disorders
Foundation
The Real Story: What We Hear
From The Patients
Ms. Terrie Cowley
President, TMJ Association
Presentations:
Co-morbid Conditions in Orofacial Pain Patients: Pathophysiologic
Implications
Captain Peter Bertrand, DDS
Chair,
Naval
National Naval
Structure and Inflammatory
Diseases of the TMJ
Stephen B. Milam, DDS, Ph.D.
Professor and Chairman
Department of Oral and
Maxillofacial Surgery
University of
Pain and Neuroendocrinology
Associated with TMJD
Christian S. Stohler, DMD, Dr. Med. Dent.
Dean
University of
Principles of Scientific
Integrative Medicine as Applied to Autonomic Disorders
David S. Goldstein, MD,
Ph.D.
Chief, Clinical Neurocardiology Section
Clinical Neurosciences
Program
NINDS, NIH
Discussants:
Gail K. Adler, MD Neuroendocrine
mechanisms
Division of Endocrinology,
Hypertension
and Diabetes
Department of Medicine
Brigham and Womens Hospital
Daniel J. Clauw, MD Multi-disciplinary approaches;
methodological challenges
Professor of Medicine,
Division of Rheumatology
Director, Center for the
Advancement of Clinical Research
University of
Allen W. Cowley, Jr., Ph.D. Genomic
influences; cardiovascular involvement
Professor and Chairman
Department of Physiology
Michael Menaker,
Ph.D. Biorhythm
physiological interactions
Commonwealth Professor of Biology
Department of Biology
Patients